Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Psoriatic keratinocytes are resistant to tumor necrosis factor alpha's induction of mRNA for the NMDA-R2C subunit.

Morhenn VB, Nahm WJ, Mansbridge JN.

Exp Dermatol. 2013 Nov;22(11):750-1. doi: 10.1111/exd.12242.

PMID:
24102971
2.

Acute generalised pustular bacterid.

Murakami M, Ishida-Yamamoto A, Morhenn VB, Sayama K.

Lancet Infect Dis. 2013 Aug;13(8):655-6. doi: 10.1016/S1473-3099(13)70103-8. No abstract available.

PMID:
23886332
3.

The rate of wound healing is increased in psoriasis.

Morhenn VB, Nelson TE, Gruol DL.

J Dermatol Sci. 2013 Nov;72(2):87-92. doi: 10.1016/j.jdermsci.2013.06.001. Epub 2013 Jun 12.

4.

Over-expression of kallikrein related peptidases in palmoplantar pustulosis.

Kaneko T, Murakami M, Kishibe M, Brattsand M, Morhenn VB, Ishida-Yamamoto A, Iizuka H.

J Dermatol Sci. 2012 Jul;67(1):73-6. doi: 10.1016/j.jdermsci.2012.03.009. Epub 2012 Apr 5. No abstract available.

PMID:
22520926
5.

Use of gelatin sponges in Mohs micrographic surgery defects and staged melanoma excisions: a novel approach to secondary wound healing.

Rullan PP, Vallbona C, Rullan JM, Mansbridge JN, Morhenn VB.

J Drugs Dermatol. 2011 Jan;10(1):68-73.

PMID:
21197526
6.

Acrosyringium is the main site of the vesicle/pustule formation in palmoplantar pustulosis.

Murakami M, Ohtake T, Horibe Y, Ishida-Yamamoto A, Morhenn VB, Gallo RL, Iizuka H.

J Invest Dermatol. 2010 Aug;130(8):2010-6. doi: 10.1038/jid.2010.87. Epub 2010 Apr 15.

7.

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.

Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL.

Nat Med. 2007 Aug;13(8):975-80. Epub 2007 Aug 5.

PMID:
17676051
9.

Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment.

Lee PH, Trowbridge JM, Taylor KR, Morhenn VB, Gallo RL.

J Biol Chem. 2004 Nov 19;279(47):48640-6. Epub 2004 Sep 3.

10.

Characterization of the expression and function of N-methyl-D-aspartate receptor in keratinocytes.

Morhenn VB, Murakami M, O'Grady T, Nordberg J, Gallo RL.

Exp Dermatol. 2004 Aug;13(8):505-11.

PMID:
15265015
11.

Migration studies and histology of injectable microspheres of different sizes in mice.

Lemperle G, Morhenn VB, Pestonjamasp V, Gallo RL.

Plast Reconstr Surg. 2004 Apr 15;113(5):1380-90.

PMID:
15060350
12.

Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells.

Morhenn VB, Lemperle G, Gallo RL.

Dermatol Surg. 2002 Jun;28(6):484-90.

PMID:
12081676
13.

Is psoriasis a T-cell disease?

Nickoloff BJ, Schröder JM, von den Driesch P, Raychaudhuri SP, Farber EM, Boehncke WH, Morhenn VB, Rosenberg EW, Schön MP, Holick MF.

Exp Dermatol. 2000 Oct;9(5):359-75.

PMID:
11016857
14.
15.

A noninvasive method for quantifying and distinguishing inflammatory skin reactions.

Morhenn VB, Chang EY, Rheins LA.

J Am Acad Dermatol. 1999 Nov;41(5 Pt 1):687-92.

PMID:
10534629
16.

Changes in the skin's capacitance after damage to the stratum corneum in humans.

Palenske J, Morhenn VB.

J Cutan Med Surg. 1999 Jan;3(3):127-31.

PMID:
10082592
17.
18.

Cell-mediated autoimmune diseases of the skin: some hypotheses.

Morhenn VB.

Med Hypotheses. 1997 Sep;49(3):241-5.

PMID:
9293469
19.
20.

Evidence for an NMDA receptor subunit in human keratinocytes and rat cardiocytes.

Morhenn VB, Waleh NS, Mansbridge JN, Unson D, Zolotorev A, Cline P, Toll L.

Eur J Pharmacol. 1994 Aug 16;268(3):409-14.

PMID:
7805765

Supplemental Content

Loading ...
Support Center